Sitagliptin alters bone composition in high-fat-fed mice

Sitagliptin alters bone composition in high-fat-fed mice

Type 2 diabetes mellitus is recognized as a significant risk factor for fragility of bone. Among the newer anti-diabetic agents, dipeptidyl peptidase-4 inhibitors (DPP4i) have been reported to decrease the occurrence of bone fractures although the reason is unclear. The main aim of this study was to...

Full description

Bibliographic Details
Main Authors: Mansur, Sity Aishah, Mieczkowska, Aleksandra, Flatt, Peter R., Chappard, Daniel, Irwin, Nigel, Mabilleau, Guillaume
Format: Article
Language:English
Published: CALCIFIED TISSUE INTERNATIONAL, Springer Link 2018
Subjects:
TP155-156 Chemical engineering
Online Access:http://eprints.uthm.edu.my/5850/
http://eprints.uthm.edu.my/5850/1/AJ%202018%20%28919%29%20Sitagliptin%20alters%20bone%20composition%20in%20high-fat-fed%20mice.pdf

Internet

http://eprints.uthm.edu.my/5850/
http://eprints.uthm.edu.my/5850/1/AJ%202018%20%28919%29%20Sitagliptin%20alters%20bone%20composition%20in%20high-fat-fed%20mice.pdf

Similar Items